BirchBioMed Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BirchBioMed Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11048
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BirchBioMed Inc (BirchBioMed) is a biomedical company that concentrate on the development, clinical evaluation and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company’s proprietary and patented lead drug candidate, FS2 is being developing which is used for the treatment of scars and autoimmune diseases. BirchBioMed’s patented, disruptive and autoimmune technology, AI-001 is used to treat Type-1 diabetes, psoriasis and alopecia. The company’s AI-001 is the combination of FS2 in conjunction with cell therapy for the treatment of autoimmune diseases. It has presence in the New York, the US. BirchBioMed is headquartered in King City, Ontario, Canada.

BirchBioMed Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BirchBioMed Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BirchBioMed Inc, Medical Devices Deals, 2012 to YTD 2018 9
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
BirchBioMed to Raise up to USD2 Million in Series A Financing 11
Birch BioMed to Raise USD10 Million in Financing Round 12
Partnerships 13
Sensus Healthcare Enters into Agreement with BirchBioMed 13
Licensing Agreements 14
BirchBioMed Enters into Licensing Agreement with University of British Columbia 14
BirchBioMed Inc – Key Competitors 15
BirchBioMed Inc – Key Employees 16
BirchBioMed Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Aug 13, 2018: Sensus Healthcare CEO Joseph C. Sardano Joins BirchBioMed Board of Directors 18
Clinical Trials 19
Feb 16, 2018: BirchBioMed is cleared to begin first-of-its-kind phase II clinical trial for ground-breaking anti-scarring drug 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
BirchBioMed Inc, Pharmaceuticals & Healthcare, Key Facts 2
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BirchBioMed Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BirchBioMed Inc, Deals By Therapy Area, 2012 to YTD 2018 8
BirchBioMed Inc, Medical Devices Deals, 2012 to YTD 2018 9
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BirchBioMed to Raise up to USD2 Million in Series A Financing 11
Birch BioMed to Raise USD10 Million in Financing Round 12
Sensus Healthcare Enters into Agreement with BirchBioMed 13
BirchBioMed Enters into Licensing Agreement with University of British Columbia 14
BirchBioMed Inc, Key Competitors 15
BirchBioMed Inc, Key Employees 16

List of Figures
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BirchBioMed Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BirchBioMed Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BirchBioMed Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SandRidge Energy Inc (SD):石油・ガス:M&Aディール及び事業提携情報
    Summary SandRidge Energy Inc (SandRidge) is an upstream energy company. It develops, explores for, and produces oil and natural gas in the Mid-Continent and Rockies regions of the US. In Mid-Continent, the company operates assets in Oklahoma and Kansas. In Rockies, SandRidge operates assets within t …
  • Chang Hwa Commercial Bank, Ltd.:企業の戦略・SWOT・財務情報
    Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Grasim Industries Limited:企業の戦略・SWOT・財務分析
    Grasim Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Grasim Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Royal KPN N.V.:企業の戦略・SWOT・財務情報
    Royal KPN N.V. - Strategy, SWOT and Corporate Finance Report Summary Royal KPN N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cabot Corp (CBT):企業の財務・戦略的SWOT分析
    Cabot Corp (CBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • National Bank Of Kuwait Sak:企業の戦略・SWOT・財務分析
    National Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report Summary National Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • BOE Technology Group Co Ltd:企業の戦略・SWOT・財務情報
    BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Kirloskar Brothers Ltd (KIRLOSBROS):企業の財務・戦略的SWOT分析
    Kirloskar Brothers Ltd (KIRLOSBROS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • New Jersey Resources Corp (NJR):石油・ガス:M&Aディール及び事業提携情報
    Summary New Jersey Resources Corp (NJR) is a provider of natural gas delivery and energy services. The company offers services such as energy services, home services, energy management services and storage facilities. Its home services include home heating services, home AC services, electrical serv …
  • Ilana Jivago Inc.:企業の戦略・SWOT・財務情報
    Ilana Jivago Inc. - Strategy, SWOT and Corporate Finance Report Summary Ilana Jivago Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Malee Group Public Company Limited:企業の戦略・SWOT・財務情報
    Malee Group Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Malee Group Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Lycatel Services Ltd:企業の戦略的SWOT分析
    Lycatel Services Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Genomind Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genomind Inc (Genomind) is a personalized medicine company that provides genetic testing services. The company offers Genecept Assay, a pharmacogenetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. Its test is used to guide treatment fo …
  • Sojitz Corp (2768):企業の財務・戦略的SWOT分析
    Sojitz Corp (2768) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Avery Dennison Corporation (AVY):企業の財務・戦略的SWOT分析
    Avery Dennison Corporation (AVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Cencosud SA:企業のM&A・事業提携・投資動向
    Cencosud SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cencosud SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Automotive Holdings Group Limited:企業のM&A・事業提携・投資動向
    Automotive Holdings Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Automotive Holdings Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • AK Steel Holding Corp:企業の戦略・SWOT・財務情報
    AK Steel Holding Corp - Strategy, SWOT and Corporate Finance Report Summary AK Steel Holding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • EVRY ASA:企業の戦略・SWOT・財務情報
    EVRY ASA - Strategy, SWOT and Corporate Finance Report Summary EVRY ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Pulse Utilities New Zealand Ltd:電力:M&Aディール及び事業提携情報
    Summary Pulse Utilities New Zealand Ltd (Pulse Energy) is a utility service provider that offers electricity distribution and related services. The company’s services include electricity reconnection and disconnection, pricing plan change, among others. It provides smart meters that enable customers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆